Agios Pharmaceuticals
AGIO
#5155
Rank
A$2.29 B
Marketcap
A$39.40
Share price
-0.62%
Change (1 day)
-29.60%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: A$2.29 Billion

As of February 2026 Agios Pharmaceuticals has a market cap of A$2.29 Billion. This makes Agios Pharmaceuticals the world's 5155th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.29 B-5.81%
2025A$2.43 B-20.34%
2024A$3.06 B67.62%
2023A$1.82 B-19.42%
2022A$2.26 B-7.92%
2021A$2.46 B-36.91%
2020A$3.90 B-16.34%
2019A$4.66 B22.42%
2018A$3.81 B6.73%
2017A$3.57 B46.78%
2016A$2.43 B-27.6%
2015A$3.35 B-33.86%
2014A$5.07 B506.25%
2013A$0.83 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Agios Pharmaceuticals was reported to be:

A$2.29 Billion
by Nasdaq info icon info icon
A$2.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$215.87 B 9,294.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.335 T 58,005.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$149.75 B 6,417.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
A$1.23 B-46.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$15.98 B 595.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.59 B 578.83%๐Ÿ‡บ๐Ÿ‡ธ USA